These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
115 related articles for article (PubMed ID: 2170718)
1. [Clinical trial of inactivated hepatitis A vaccine]. Iino S; Fujiyama S; Horiuchi K; Jo K Nihon Shokakibyo Gakkai Zasshi; 1990 Jul; 87(7):1532-6. PubMed ID: 2170718 [TBL] [Abstract][Full Text] [Related]
2. Immunogenicity, safety and tolerability of varying doses and regimens of inactivated hepatitis A virus vaccine in Navajo children. Newcomer W; Rivin B; Reid R; Moulton LH; Wolff M; Croll J; Johnson C; Brown L; Nalin D; Santosham M Pediatr Infect Dis J; 1994 Jul; 13(7):640-2. PubMed ID: 7970954 [TBL] [Abstract][Full Text] [Related]
3. Comparison of immunogenicity of two hepatitis A vaccines--VAQTA and HAVRIX--in young adults. Ashur Y; Adler R; Rowe M; Shouval D Vaccine; 1999 May; 17(18):2290-6. PubMed ID: 10403597 [TBL] [Abstract][Full Text] [Related]
4. Immunogenicity and safety of an inactivated hepatitis A vaccine in Taiwanese adults and children. Lee CY; Huang LM; Lee PI; Chiu HH; Dumas R; Milcamps B; Lin W Southeast Asian J Trop Med Public Health; 2000 Mar; 31(1):29-36. PubMed ID: 11023061 [TBL] [Abstract][Full Text] [Related]
5. A trial of the reactogenicity and immunogenicity of an inactivated hepatitis A vaccine. Green MS; Cohen D; Lerman Y; Sjogren M; Binn LN; Zur S; Slepon R; Robin G; Hoke C; Bancroft W Isr J Med Sci; 1994; 30(5-6):485-8. PubMed ID: 8034508 [TBL] [Abstract][Full Text] [Related]
6. Clinical trial to evaluate immunogenicity and safety of inactivated hepatitis A vaccination starting at 2-month-old children. Kanra G; Yalçin SS; Ceyhan M; Yurdakök K Turk J Pediatr; 2000; 42(2):105-8. PubMed ID: 10936974 [TBL] [Abstract][Full Text] [Related]
7. Reactogenicity and immunogenicity of three different lots of a hepatitis A vaccine. Theilmann L; Kallinowski B; Gmelin K; Hofmann F; Scheiermann N; Wohland B; Stickl H; Maiwald H; Moriabadi FK; Bock HL Vaccine; 1992; 10 Suppl 1():S132-4. PubMed ID: 1335644 [TBL] [Abstract][Full Text] [Related]
8. Placebo-controlled efficacy study of hepatitis A vaccine in Valdivia, Chile. Riedemann S; Reinhardt G; Frösner GG; Ibarra H; Moraleda L; Hering V; Siegel F; Toledo C; Leon J; Gonzalez JL Vaccine; 1992; 10 Suppl 1():S152-5. PubMed ID: 1335650 [TBL] [Abstract][Full Text] [Related]
9. Clinical assessment of the safety and efficacy of an inactivated hepatitis A vaccine: rationale and summary of findings. André FE; D'Hondt E; Delem A; Safary A Vaccine; 1992; 10 Suppl 1():S160-8. PubMed ID: 1335652 [TBL] [Abstract][Full Text] [Related]
10. Immunogenicity and safety of a new inactivated hepatitis A vaccine in a comparative study. Goilav C; Zuckerman J; Lafrenz M; Vidor E; Lauwers S; Ratheau C; Benichou G; Zuckerman A J Med Virol; 1995 Jul; 46(3):287-92. PubMed ID: 7561805 [TBL] [Abstract][Full Text] [Related]
11. Inactivated hepatitis A vaccine: reactogenicity, immunogenicity, and long-term antibody persistence. Van Damme P; Thoelen S; Cramm M; De Groote K; Safary A; Meheus A J Med Virol; 1994 Dec; 44(4):446-51. PubMed ID: 7897379 [TBL] [Abstract][Full Text] [Related]
12. Inactivated hepatitis A vaccine: a safety and immunogenicity study in health professionals. Davidson M; Krugman S; Sandman LA Vaccine; 1992; 10 Suppl 1():S119-20. PubMed ID: 1335639 [TBL] [Abstract][Full Text] [Related]
13. Simultaneous active and passive immunization against hepatitis A studied in a population of travellers. Wagner G; Lavanchy D; Darioli R; Pécoud A; Brulein V; Safary A; Frei PC Vaccine; 1993; 11(10):1027-32. PubMed ID: 8212822 [TBL] [Abstract][Full Text] [Related]
14. Hepatitis A antibody titres after infection and immunization: implications for passive and active immunization. Zaaijer HL; Leentvaar-Kuijpers A; Rotman H; Lelie PN J Med Virol; 1993 May; 40(1):22-7. PubMed ID: 8515245 [TBL] [Abstract][Full Text] [Related]
15. [Immune response to one booster dose of inactivated hepatitis A vaccine in college students]. Liao Z; Feng XW; Liu XE; Zhou YS; Wen HR; Peng SH; Zhang YX; Xu B; Zhuang H; Chen HY Zhonghua Liu Xing Bing Xue Za Zhi; 2017 May; 38(5):625-628. PubMed ID: 28651399 [No Abstract] [Full Text] [Related]
16. Reactogenicity and immunogenicity of inactivated hepatitis A vaccines. Just M; Berger R Vaccine; 1992; 10 Suppl 1():S110-3. PubMed ID: 1362031 [TBL] [Abstract][Full Text] [Related]
17. Inactivated hepatitis A vaccine: active and passive immunoprophylaxis in chimpanzees. Purcell RH; D'Hondt E; Bradbury R; Emerson SU; Govindarajan S; Binn L Vaccine; 1992; 10 Suppl 1():S148-51. PubMed ID: 1335648 [TBL] [Abstract][Full Text] [Related]
18. [The immunogenicity of a cultured inactivated hepatitis A vaccine]. Kusov IuIu; El'bert LB; Kazachkov IuA; Val'iano NM; Nel'ga IV; Grishina GK; Krutianskaia GL; Lisitsyna EA; Poleshchuk VF; Sobol' AV Vopr Virusol; 1991; 36(3):206-9. PubMed ID: 1654007 [TBL] [Abstract][Full Text] [Related]
19. Safety, immunogenicity and antibody persistence of an inactivated hepatitis A vaccine in 4 to 15 year old children. Castillo de Febres O; Chacon de Petrola M; Casanova de Escalona L; Naveda O; Naveda M; Estopinan M; Bordones G; Zambrano B; Garcia A; Dumas R Vaccine; 1999 Nov; 18(7-8):656-64. PubMed ID: 10547425 [TBL] [Abstract][Full Text] [Related]
20. Depression of the immune response to an inactivated hepatitis A vaccine administered concomitantly with immune globulin. Green MS; Cohen D; Lerman Y; Sjogren M; Binn LN; Zur S; Slepon R; Robin G; Hoke C; Bancroft W J Infect Dis; 1993 Sep; 168(3):740-3. PubMed ID: 8394864 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]